Donate to Illuminate Contact TSF
Visit us on Facebook Visit us on Twitter Visit us on YouTube Visit us on Instagram Visit us on Linkedin Visit us on Tiktok

Choose Your Language:

2020 Grant Recipients

Posted by: The Sumaira Foundation in News & Announcements

November 9, 2020 – We are proud to announce the grant recipients of TSF’s 2020 research grants. Congratulations to our recipients who received $25,000 to initiate their projects!

Diagnostics in NMOSD

Farrah Mateen, MD, PhD | Massachusetts General Hospital (Boston, MA)

Aim: To pilot a novel point-of-care dry blood spot diagnostic test for patients with aquaporin 4-antibody  (AQP4) seropositive neuromyelitis optica spectrum disorder (NMOSD)

 A Point-of-Care Diagnostic Test for Aquaporin-4 Antibody Seropositive Neuromyelitis Optica

MOG Statin

Michael Levy, MD, PhD | Massachusetts General Hospital (Boston, MA)

Aim: To repurpose existing medications to stop the inflammatory process in patients with MOG antibody disease

Autoantibodies in NMOSD

Stacey Clardy, MD, PhD & Jonathan Galli, MD | University of Utah (Salt Lake City, UT)


Describe the epidemiologic characteristics of all patients who carry a diagnosis of NMOSD within the Department of Defense/Defense Medical Surveillance System (DMSS).

Confirm the presence of Aquaporin-4 and MOG autoantibodies in pre-symptomatic NMO samples

Investigating a Relapse Biomarker in MOG-AD

Tanuja Chitnis, MD | Brigham and Women’s Hospital (Boston, MA)


To evaluate dynamics of TNFAIP3 as a relapse biomarker in adults and children with MOG-AD

To evaluate the effects endogenous and exogenous steroids on levels of TNFAIP3 in patients  with MOG-AD

Industry Partners

Community Partners

WARNING: Internet Explorer does not support modern web standards. This site may not function correctly on this browser and is best viewed on Chrome, Firefox or Edge browsers. Learn More.